Castration-Resistant Prostate Cancer (CRPC) Market Report

China Castration-Resistant Prostate Cancer (CRPC) Industry Market Research Report 2023-2029

  • POSTDATE：Oct 03, 2023
  • PAGES：173
  • REPORT CODE：GMM1822661
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Castration-Resistant Prostate Cancer (CRPC) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Sanofi

    • Pfizer, Inc

    • Bayer AG

    • Johnson & Johnson Services, Inc

    By Type:

    • Radiotherapy

    • Chemotherapy

    • Immunotherapy

    • Hormonal Therapy

    By Application:

    • Hospitals

    • Specialty Centers

    • Ambulatory Surgical Centers

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Castration-Resistant Prostate Cancer (CRPC) Market Overview 2018-2029

    • 1.1 China Castration-Resistant Prostate Cancer (CRPC) Industry Development Overview

    • 1.2 China Castration-Resistant Prostate Cancer (CRPC) Industry Development History

    • 1.3 China Castration-Resistant Prostate Cancer (CRPC) Industry Market Size (2018-2029)

    • 1.4 China Castration-Resistant Prostate Cancer (CRPC) Market Analysis by Type from Production Side

      • 1.4.1 China Castration-Resistant Prostate Cancer (CRPC) Production Volume, Production Value and Growth Rate of Radiotherapy (2018-2029)

      • 1.4.2 China Castration-Resistant Prostate Cancer (CRPC) Production Volume, Production Value and Growth Rate of Chemotherapy (2018-2029)

      • 1.4.3 China Castration-Resistant Prostate Cancer (CRPC) Production Volume, Production Value and Growth Rate of Immunotherapy (2018-2029)

      • 1.4.4 China Castration-Resistant Prostate Cancer (CRPC) Production Volume, Production Value and Growth Rate of Hormonal Therapy (2018-2029)

    • 1.5 China Castration-Resistant Prostate Cancer (CRPC) Market Analysis by Application from Consumption End

      • 1.5.1 China Castration-Resistant Prostate Cancer (CRPC) Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

      • 1.5.2 China Castration-Resistant Prostate Cancer (CRPC) Sales Volume, Sales Value and Growth Rate of Specialty Centers (2018-2029)

      • 1.5.3 China Castration-Resistant Prostate Cancer (CRPC) Sales Volume, Sales Value and Growth Rate of Ambulatory Surgical Centers (2018-2029)

    • 1.6 China Castration-Resistant Prostate Cancer (CRPC) Market Analysis by Region

      • 1.6.1 North China Castration-Resistant Prostate Cancer (CRPC) Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Castration-Resistant Prostate Cancer (CRPC) Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Castration-Resistant Prostate Cancer (CRPC) Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Castration-Resistant Prostate Cancer (CRPC) Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Castration-Resistant Prostate Cancer (CRPC) Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Castration-Resistant Prostate Cancer (CRPC) Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Castration-Resistant Prostate Cancer (CRPC) Market Size and Growth Rate from 2018-2029

    Chapter 2 China Castration-Resistant Prostate Cancer (CRPC) Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Castration-Resistant Prostate Cancer (CRPC) Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Castration-Resistant Prostate Cancer (CRPC) Market Status and Competition Analysis in 2023

      • 2.2.3 China Castration-Resistant Prostate Cancer (CRPC) Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Castration-Resistant Prostate Cancer (CRPC) Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Castration-Resistant Prostate Cancer (CRPC) Industry Development

    Chapter 3 Castration-Resistant Prostate Cancer (CRPC)Industry Chain Analysis

    • 3.1 Castration-Resistant Prostate Cancer (CRPC) Industry Chain

    • 3.2 Castration-Resistant Prostate Cancer (CRPC) Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Castration-Resistant Prostate Cancer (CRPC) Market

    • 3.3 Castration-Resistant Prostate Cancer (CRPC) Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Castration-Resistant Prostate Cancer (CRPC) Market

    Chapter 4 China Castration-Resistant Prostate Cancer (CRPC) Market, by Type

    • 4.1 China Castration-Resistant Prostate Cancer (CRPC) Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Castration-Resistant Prostate Cancer (CRPC) Total Production Volume and Growth Rate from Production Side

    • 4.5 China Castration-Resistant Prostate Cancer (CRPC) Production Volume and Growth Rate, by Type

      • 4.5.1 China Castration-Resistant Prostate Cancer (CRPC) Production Volume and Growth Rate of Radiotherapy

      • 4.5.2 China Castration-Resistant Prostate Cancer (CRPC) Production Volume and Growth Rate of Chemotherapy

      • 4.5.3 China Castration-Resistant Prostate Cancer (CRPC) Production Volume and Growth Rate of Immunotherapy

      • 4.5.4 China Castration-Resistant Prostate Cancer (CRPC) Production Volume and Growth Rate of Hormonal Therapy

    Chapter 5 China Castration-Resistant Prostate Cancer (CRPC) Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Castration-Resistant Prostate Cancer (CRPC) Total Market Size and Growth Rate from Consumption End

    • 5.5 China Castration-Resistant Prostate Cancer (CRPC) Market Size and Growth Rate, by Application

      • 5.5.1 China Castration-Resistant Prostate Cancer (CRPC) Market Size and Growth Rate of Hospitals

      • 5.5.2 China Castration-Resistant Prostate Cancer (CRPC) Market Size and Growth Rate of Specialty Centers

      • 5.5.3 China Castration-Resistant Prostate Cancer (CRPC) Market Size and Growth Rate of Ambulatory Surgical Centers

    Chapter 6 China Castration-Resistant Prostate Cancer (CRPC) Market, by Region

    • 6.1 China Castration-Resistant Prostate Cancer (CRPC) Production Volume and Production Value, by Region

    • 6.2 China Castration-Resistant Prostate Cancer (CRPC) Sales Volume and Sales Value, by Region

    Chapter 7 North China Castration-Resistant Prostate Cancer (CRPC) Market Analysis

    • 7.1 North China Castration-Resistant Prostate Cancer (CRPC) Market, by Type

    • 7.2 North China Castration-Resistant Prostate Cancer (CRPC) Market, by Application

    Chapter 8 Central China Castration-Resistant Prostate Cancer (CRPC) Market Analysis

    • 8.1 Central China Castration-Resistant Prostate Cancer (CRPC) Market, by Type

    • 8.2 Central China Castration-Resistant Prostate Cancer (CRPC) Market, by Application

    Chapter 9 South China Castration-Resistant Prostate Cancer (CRPC) Market Analysis

    • 9.1 South China Castration-Resistant Prostate Cancer (CRPC) Market, by Type

    • 9.2 South China Castration-Resistant Prostate Cancer (CRPC) Market, by Application

    Chapter 10 East China Castration-Resistant Prostate Cancer (CRPC) Market Analysis

    • 10.1 East China Castration-Resistant Prostate Cancer (CRPC) Market, by Type

    • 10.2 East China Castration-Resistant Prostate Cancer (CRPC) Market, by Application

    Chapter 11 Northeast China Castration-Resistant Prostate Cancer (CRPC) Market Analysis

    • 11.1 Northeast China Castration-Resistant Prostate Cancer (CRPC) Market, by Type

    • 11.2 Northeast China Castration-Resistant Prostate Cancer (CRPC) Market, by Application

    Chapter 12 Southwest China Castration-Resistant Prostate Cancer (CRPC) Market Analysis

    • 12.1 Southwest China Castration-Resistant Prostate Cancer (CRPC) Market, by Type

    • 12.2 Southwest China Castration-Resistant Prostate Cancer (CRPC) Market, by Application

    Chapter 13 Northwest China Castration-Resistant Prostate Cancer (CRPC) Market Analysis

    • 13.1 Northwest China Castration-Resistant Prostate Cancer (CRPC) Market, by Type

    • 13.2 Northwest China Castration-Resistant Prostate Cancer (CRPC) Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Sanofi

        • 14.1.1 Sanofi Company Profile

        • 14.1.2 Sanofi Castration-Resistant Prostate Cancer (CRPC) Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Pfizer, Inc

        • 14.2.1 Pfizer, Inc Company Profile

        • 14.2.2 Pfizer, Inc Castration-Resistant Prostate Cancer (CRPC) Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Bayer AG

        • 14.3.1 Bayer AG Company Profile

        • 14.3.2 Bayer AG Castration-Resistant Prostate Cancer (CRPC) Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Johnson & Johnson Services, Inc

        • 14.4.1 Johnson & Johnson Services, Inc Company Profile

        • 14.4.2 Johnson & Johnson Services, Inc Castration-Resistant Prostate Cancer (CRPC) Market Performance

        • 14.4.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Castration-Resistant Prostate Cancer (CRPC) Industry Research Conclusions

    • 15.2 Castration-Resistant Prostate Cancer (CRPC) Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Castration-Resistant Prostate Cancer (CRPC) Industry Market Size (2018-2029)

    • Figure China Castration-Resistant Prostate Cancer (CRPC) Production Volume, Production Value and Growth Rate of Radiotherapy (2018-2029)

    • Figure China Castration-Resistant Prostate Cancer (CRPC) Production Volume, Production Value and Growth Rate of Chemotherapy (2018-2029)

    • Figure China Castration-Resistant Prostate Cancer (CRPC) Production Volume, Production Value and Growth Rate of Immunotherapy (2018-2029)

    • Figure China Castration-Resistant Prostate Cancer (CRPC) Production Volume, Production Value and Growth Rate of Hormonal Therapy (2018-2029)

    • Figure China Castration-Resistant Prostate Cancer (CRPC) Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • Figure China Castration-Resistant Prostate Cancer (CRPC) Sales Volume, Sales Value and Growth Rate of Specialty Centers (2018-2029)

    • Figure China Castration-Resistant Prostate Cancer (CRPC) Sales Volume, Sales Value and Growth Rate of Ambulatory Surgical Centers (2018-2029)

    • Figure North China Castration-Resistant Prostate Cancer (CRPC) Market Size and Growth Rate from 2018-2029

    • Figure Central China Castration-Resistant Prostate Cancer (CRPC) Market Size and Growth Rate from 2018-2029

    • Figure South China Castration-Resistant Prostate Cancer (CRPC) Market Size and Growth Rate from 2018-2029

    • Figure East China Castration-Resistant Prostate Cancer (CRPC) Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Castration-Resistant Prostate Cancer (CRPC) Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Castration-Resistant Prostate Cancer (CRPC) Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Castration-Resistant Prostate Cancer (CRPC) Market Size and Growth Rate from 2018-2029

    • Figure Castration-Resistant Prostate Cancer (CRPC) Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Castration-Resistant Prostate Cancer (CRPC) Market Share by Type in 2018

    • Figure China Castration-Resistant Prostate Cancer (CRPC) Market Share by Type in 2023

    • Figure China Castration-Resistant Prostate Cancer (CRPC) Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Castration-Resistant Prostate Cancer (CRPC) Production Volume and Growth Rate of Radiotherapy (2018-2023)

    • Figure China Castration-Resistant Prostate Cancer (CRPC) Production Volume and Growth Rate of Chemotherapy (2018-2023)

    • Figure China Castration-Resistant Prostate Cancer (CRPC) Production Volume and Growth Rate of Immunotherapy (2018-2023)

    • Figure China Castration-Resistant Prostate Cancer (CRPC) Production Volume and Growth Rate of Hormonal Therapy (2018-2023)

    • Figure China Castration-Resistant Prostate Cancer (CRPC) Market Share by Application in 2018

    • Figure China Castration-Resistant Prostate Cancer (CRPC) Market Share by Application in 2023

    • Figure China Castration-Resistant Prostate Cancer (CRPC) Total Market Size and Growth Rate from Consumption End

    • Figure China Castration-Resistant Prostate Cancer (CRPC) Market Size and Growth Rate of Hospitals (2018-2023)

    • Figure China Castration-Resistant Prostate Cancer (CRPC) Market Size and Growth Rate of Specialty Centers (2018-2023)

    • Figure China Castration-Resistant Prostate Cancer (CRPC) Market Size and Growth Rate of Ambulatory Surgical Centers (2018-2023)

    • Table China Castration-Resistant Prostate Cancer (CRPC) Production Volume by Region (2018-2023)

    • Table China Castration-Resistant Prostate Cancer (CRPC) Production Volume Share by Region (2018-2023)

    • Figure China Castration-Resistant Prostate Cancer (CRPC) Production Volume Share by Region (2018-2023)

    • Table China Castration-Resistant Prostate Cancer (CRPC) Production Value by Region (2018-2023)

    • Table China Castration-Resistant Prostate Cancer (CRPC) Production Value Share by Region (2018-2023)

    • Figure China Castration-Resistant Prostate Cancer (CRPC) Production Value Share by Region (2018-2023)

    • Table China Castration-Resistant Prostate Cancer (CRPC) Sales Volume by Region (2018-2023)

    • Table China Castration-Resistant Prostate Cancer (CRPC) Sales Volume Share by Region (2018-2023)

    • Figure China Castration-Resistant Prostate Cancer (CRPC) Sales Volume Share by Region (2018-2023)

    • Table China Castration-Resistant Prostate Cancer (CRPC) Sales Value by Region (2018-2023)

    • Table China Castration-Resistant Prostate Cancer (CRPC) Sales Value Share by Region (2018-2023)

    • Figure China Castration-Resistant Prostate Cancer (CRPC) Sales Value Share by Region (2018-2023)

    • Table North China Castration-Resistant Prostate Cancer (CRPC) Production Volume by Type (2018-2023)

    • Table North China Castration-Resistant Prostate Cancer (CRPC) Production Volume Share by Type (2018-2023)

    • Figure North China Castration-Resistant Prostate Cancer (CRPC) Production Volume Share by Type (2018-2023)

    • Table North China Castration-Resistant Prostate Cancer (CRPC) Sales Volume by Application (2018-2023)

    • Table North China Castration-Resistant Prostate Cancer (CRPC) Sales Volume Share by Application (2018-2023)

    • Figure North China Castration-Resistant Prostate Cancer (CRPC) Sales Volume Share by Application (2018-2023)

    • Table Central China Castration-Resistant Prostate Cancer (CRPC) Production Volume by Type (2018-2023)

    • Table Central China Castration-Resistant Prostate Cancer (CRPC) Production Volume Share by Type (2018-2023)

    • Figure Central China Castration-Resistant Prostate Cancer (CRPC) Production Volume Share by Type (2018-2023)

    • Table Central China Castration-Resistant Prostate Cancer (CRPC) Sales Volume by Application (2018-2023)

    • Table Central China Castration-Resistant Prostate Cancer (CRPC) Sales Volume Share by Application (2018-2023)

    • Figure Central China Castration-Resistant Prostate Cancer (CRPC) Sales Volume Share by Application (2018-2023)

    • Table South China Castration-Resistant Prostate Cancer (CRPC) Production Volume by Type (2018-2023)

    • Table South China Castration-Resistant Prostate Cancer (CRPC) Production Volume Share by Type (2018-2023)

    • Figure South China Castration-Resistant Prostate Cancer (CRPC) Production Volume Share by Type (2018-2023)

    • Table South China Castration-Resistant Prostate Cancer (CRPC) Sales Volume by Application (2018-2023)

    • Table South China Castration-Resistant Prostate Cancer (CRPC) Sales Volume Share by Application (2018-2023)

    • Figure South China Castration-Resistant Prostate Cancer (CRPC) Sales Volume Share by Application (2018-2023)

    • Table East China Castration-Resistant Prostate Cancer (CRPC) Production Volume by Type (2018-2023)

    • Table East China Castration-Resistant Prostate Cancer (CRPC) Production Volume Share by Type (2018-2023)

    • Figure East China Castration-Resistant Prostate Cancer (CRPC) Production Volume Share by Type (2018-2023)

    • Table East China Castration-Resistant Prostate Cancer (CRPC) Sales Volume by Application (2018-2023)

    • Table East China Castration-Resistant Prostate Cancer (CRPC) Sales Volume Share by Application (2018-2023)

    • Figure East China Castration-Resistant Prostate Cancer (CRPC) Sales Volume Share by Application (2018-2023)

    • Table Northeast China Castration-Resistant Prostate Cancer (CRPC) Production Volume by Type (2018-2023)

    • Table Northeast China Castration-Resistant Prostate Cancer (CRPC) Production Volume Share by Type (2018-2023)

    • Figure Northeast China Castration-Resistant Prostate Cancer (CRPC) Production Volume Share by Type (2018-2023)

    • Table Northeast China Castration-Resistant Prostate Cancer (CRPC) Sales Volume by Application (2018-2023)

    • Table Northeast China Castration-Resistant Prostate Cancer (CRPC) Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Castration-Resistant Prostate Cancer (CRPC) Sales Volume Share by Application (2018-2023)

    • Table Southwest China Castration-Resistant Prostate Cancer (CRPC) Production Volume by Type (2018-2023)

    • Table Southwest China Castration-Resistant Prostate Cancer (CRPC) Production Volume Share by Type (2018-2023)

    • Figure Southwest China Castration-Resistant Prostate Cancer (CRPC) Production Volume Share by Type (2018-2023)

    • Table Southwest China Castration-Resistant Prostate Cancer (CRPC) Sales Volume by Application (2018-2023)

    • Table Southwest China Castration-Resistant Prostate Cancer (CRPC) Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Castration-Resistant Prostate Cancer (CRPC) Sales Volume Share by Application (2018-2023)

    • Table Northwest China Castration-Resistant Prostate Cancer (CRPC) Production Volume by Type (2018-2023)

    • Table Northwest China Castration-Resistant Prostate Cancer (CRPC) Production Volume Share by Type (2018-2023)

    • Figure Northwest China Castration-Resistant Prostate Cancer (CRPC) Production Volume Share by Type (2018-2023)

    • Table Northwest China Castration-Resistant Prostate Cancer (CRPC) Sales Volume by Application (2018-2023)

    • Table Northwest China Castration-Resistant Prostate Cancer (CRPC) Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Castration-Resistant Prostate Cancer (CRPC) Sales Volume Share by Application (2018-2023)

    • Table Sanofi Company Profile

    • Table Sanofi Castration-Resistant Prostate Cancer (CRPC) Revenue, Price and Gross (2018-2023)

    • Table Pfizer, Inc Company Profile

    • Table Pfizer, Inc Castration-Resistant Prostate Cancer (CRPC) Revenue, Price and Gross (2018-2023)

    • Table Bayer AG Company Profile

    • Table Bayer AG Castration-Resistant Prostate Cancer (CRPC) Revenue, Price and Gross (2018-2023)

    • Table Johnson & Johnson Services, Inc Company Profile

    • Table Johnson & Johnson Services, Inc Castration-Resistant Prostate Cancer (CRPC) Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US